Skip to content

AARD AARD Operating Lease Liabilities

Operating Lease Liabilities at other companies

Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
$3.16M-17.6%
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
$4.16M-13.7%
Arvinas logo
ArvinasARVN
$6.3M-22.2%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$7.44M-24.1%

Other financials

Income statement

See full
Revenue-
Operating income-$22.5M-115%
Net income-$21.6M-132%
EPS (diluted)-$0.99-39.4%

Balance sheet

See full
Cash & equivalents$62.4M+136%
Total debt$336.0K-53.7%
Total equity$87.0M-42.3%
Total assets$98.6M-37.2%

Cash flow

See full
Operating cash flow-$18.9M-65.7%
CapEx--100%
Free cash flow-$16.8M-117%

Valuation

See full
Market cap$124.35M-58.6%
Enterprise value$62.25M-77.4%

Returns & leverage

See full
Return on equity-58.8%
Debt / equity0.0×
Current ratio8.1×-17.8×

Where this comes from

Reported directly by AARD in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.

The official record: AARD’s 10-K, filed March 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about AARD's operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AARD's operating lease liabilities?
AARD (AARD) reported operating lease liabilities of $0 in Q4 2025.
How has AARD's operating lease liabilities changed year-over-year?
AARD's operating lease liabilities decreased by 100.0% year-over-year, from $441K to $0.
What does operating lease liabilities mean?
Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.